RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma von Ravaud, A., Barrios, C.H., Alekseev, B., Tay, M.-H., Agarwala, S.S., Yalcin, S., Lin, C.-C., Roman, L., Shkolnik, M., Anak, O., Gogov, S., Pelov, D., Louveau, A.-L., Melichar, B.

Volltext

NK cells and solid tumors: therapeutic potential and persisting obstacles von Tong, Le, Jiménez-Cortegana, Carlos, Tay, Apple H M, Wickström, Stina, Galluzzi, Lorenzo, Lundqvist, Andreas

Volltext

Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients von Lim, S-T, Wong, E-H, Chuah, K-L, Leong, S-S, Lim, W-T, Tay, M-H, Toh, C-K, Tan, E-H

Volltext

Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate von Tay, M.-H., Kaufman, D. S., Regan, M. M., Leibowitz, S. B., George, D. J, Febbo, P. G., Manola, J., Smith, M. R., Kaplan, I. D., Kantoff, P. W., Oh, W. K.

Volltext

FPR2 Shapes an Immune-Excluded Pancreatic Tumor Microenvironment and Drives T-cell Exhaustion in a Sex-Dependent Manner von He, Fei, Tay, Apple H M, Calandigary, Ahmed, Malki, Enana, Suzuki, Sayaka, Liu, Tianjie, Wang, Qi, Fernández-Moro, Carlos, Kaisso, Marina, Olofsson-Sahl, Peter, Melssen, Marit, Sze, Siu Kwan, Björnstedt, Mikael, Löhr, Matthias J, Karlsson, Mikael C I, Heuchel, Rainer, Sarhan, Dhifaf

Volltext

An evaluation of point-of-care instrument for monitoring anticoagulation level in adult cardiac patients von TAY, M. H, TIEN, S. L, CHUA, T. S. J, SIM, L. L, KOH, T. H

Volltext

An interesting case of left atrial myxoma von TAY, M. H, LAU, K. W, DING, Z. P, LEE, C. N

Volltext

Measuring quality of life in Chinese cancer patients: a new version of the Functional Living Index for Cancer (Chinese) von Cheung, Y B, Ng, G Y, Wong, L C, Koo, W H, Tan, E H, Tay, M H, Lim, D, Poon, D, Goh, C, Tan, S B

Volltext

53LRG1 is a novel regulator of endothelial activation and is shear dependent: a potential therapeutic target? von Pang, K, Fhu, C W, Ghim, M, Tay, H M, Hou, H W, Lu, Q, Warboys, C M, Wang, X, Weinberg, P D

Volltext

Attitudes towards cancer survivors: a small survey von Chen, H M K, Tan, W H, Tan, W C, Yu, C K E, Lim, T H J, Tay, M H, See, H T

Volltext

Preservation of Anticancer and Immunosuppressive Properties of Rapamycin Achieved Through Controlled Releasing Particles von Fan, Yan Liang, Hou, Han Wei, Tay, Hui Min, Guo, Wei Mei, Berggren, Per-Olof, Loo, Say Chye Joachim

Volltext

Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access prot... von Sternberg, Cora N, Dr, Castellano, Daniel, MD, Daugaard, Gedske, Prof, Géczi, Lajos, MD, Hotte, Sebastien J, MD, Mainwaring, Paul N, MD, Saad, Fred, Prof, Souza, Ciro, MD, Tay, Miah H, MD, Garrido, José M Tello, MD, Galli, Luca, MD, Londhe, Anil, PhD, De Porre, Peter, MD, Goon, Betty, BS, Lee, Emma, PhD, McGowan, Tracy, MD, Naini, Vahid, PharmD, Todd, Mary B, DO, Molina, Arturo, MD, George, Daniel J, MD

Volltext

After-hour home care service provided by a hospice in Singapore von Tay, M H, Koo, W H, Huang, D T

Volltext

Unusual case of bowel infarction with invasive Aspergillus in an immunocompromised patient von Tay, M H, Balram, C, Foo, K F, Busmanis, I, Raman, S, Khoo, K S

Volltext

Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: A phase II trial using a triplet combination von LEONG, Swan-Swan, WEE, Joseph, MIAH HIANG TAY, CHEE KEONG TOH, SAY BENG TAN, CHOON HUA THNG, KIAN FONG FOO, WAN TECK LIM, TAN, Terence, ENG HUAT TAN

Volltext

AN EXPLICIT HYBRID STABILIZED EIGHTEEN-NODE SOLID ELEMENT FOR THIN SHELL ANALYSIS von SZE, K. Y., YI, S., TAY, M. H.

Volltext

Order Effects in the Assessment of Quality of Life in Cancer Patients von Yin-Bun Cheung, Lea-Choung Wong, Miah-Hiang Tay, Chee-Keong Toh, Wen-Hsin Koo, Epstein, Richard, Cynthia Goh

Volltext

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and leucovorin in patients with metastatic nasopharyngeal carcinoma von Leong, S. S., Wee, J., Rajan, S., Poon, D., Toh, C. K., Lim, D., Tay, M. H., Foo, K. F., Tan, E. H.

Volltext

Docetaxel plus carboplatin (DC) may have significant activity in hormone refractory prostate cancer (HRPC) patients who have progressed after prior docetaxel-based chemotherapy von Tay, M. H., George, D. J., Gilligan, T. D., Kelly, S. M., Appleby, L., Taplin, M.-E., Febbo, P. G., Kantoff, P. W., Oh, W. K.

Volltext

Docetaxel plus carboplatin (DC) may have significant activity in hormone refractory prostate cancer (HRPC) patients who have progressed after prior docetaxel-based chemotherapy von Tay, M. H., George, D. J., Gilligan, T. D., Kelly, S. M., Appleby, L., Taplin, M.-E., Febbo, P. G., Kantoff, P. W., Oh, W. K.

Volltext